Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101709023A details a novel synthesis for 2,2',6,6'-tetrahydroxy biphenyl ligands, offering high yields and simplified chiral catalyst production for pharmaceutical applications.
Patent CN110684018A reveals a novel Pd-catalyzed route for 3-indolyl rhamnosides, offering high yields and step economy for reliable pharmaceutical intermediate supply chains.
Advanced Raney Nickel reduction process for high-purity iopromide intermediates. Cost-effective, atmospheric pressure synthesis suitable for commercial scale-up.
Patent CN107298694A reveals a novel Obeticholic Acid synthesis route using cholic acid. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107746393A reveals high-purity synthesis for quaternary ammonium salt 73. Achieve significant cost reduction and supply chain reliability.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed synthesis offers high efficiency and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains seeking reliable partners.
Patent CN103992212B details a novel cis-benvitimod synthesis enabling high-purity standards and cost reduction in API intermediate manufacturing for global supply chains.
Novel patent CN108069831A enables high-purity 2,3-dimethyl-4-fluorophenol production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN103695486A reveals a novel one-pot enzymatic route for Atorvastatin intermediates, offering significant cost reduction and safer manufacturing for global API producers.
Novel synthesis method for Rucaparib intermediate offers high purity and safety. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106977488B reveals visible light promoted synthesis. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Advanced synthesis of Quinapril Hydrochloride via tert-butyl ester route. Eliminates hydrogenolysis, reduces impurities, and ensures high-purity API intermediate supply.
Novel biocatalytic route for sitagliptin intermediates offers high ee value and green manufacturing advantages for pharmaceutical supply chains globally.
Patent CN109608345B reveals a novel nickel-catalyzed route for Bromfenac intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102442994A details a novel atmospheric racemization method for S-Lipoic Acid, enabling cost-effective production of high-purity R-Lipoic Acid intermediates.
Novel catalytic dehydration method using ethylene glycol replaces hazardous ethylene oxide. High yield, safe process for pharmaceutical intermediates.
Patent CN117187840A details green electrochemical amidation. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN117402055B reveals a high-yield oxidation-dechlorination route for m-fluorobenzoic acid from waste mother liquor, offering cost-effective pharma intermediate manufacturing.
Discover the patented method for converting acetophenone mother liquor into high-purity m-fluorobenzoic acid. A cost-effective solution for pharmaceutical supply chains.